Researcher
Gaëtan Devos
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → 18 Dec 2022 - Woman and Child (Division)
Member
From17 Sep 2018 → 31 Dec 2018
Projects
1 - 1 of 1
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 18 Nov 2022Funding: FWO fellowships
Publications
31 - 40 of 60
- PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment(2020)
Authors: Gaëtan Devos, Steven Joniau
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial(2020)
Authors: Charlien Berghen, Steven Joniau, Kato Rans, Gaëtan Devos, Herlinde Dumez, Maarten Albersen, Karolien Goffin, Karin Haustermans, Gert De Meerleer
- Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news(2020)
Authors: Charlien Berghen, Steven Joniau, Maarten Albersen, Gaëtan Devos, Kato Rans, Karin Haustermans, Gert De Meerleer
- ASSOCIATION BETWEEN THE EXTENT OF LYMPH NODE DISSECTION AND SEVERE TOXICITY IN MEN WITH PROSTATE CANCER TREATED WITH POST-PROSTATECTOMY RADIATION THERAPY: RESULTS FROM A LARGE MULTI-INSTITUTIONAL SERIES(2020)
Authors: Nicola Fossati, Jeffrey Karnes, Stephen A Boorjian, Giovanni Motterle, Alberto Bossi, Kumar Tamizhanban, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, Elio Mazzone, et al.
Pages: E564 - E564 - LONG-TERM OUTCOMES OF CLINICALLY NODE-POSITIVE PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT: PATTERNS OF RECURRENCE AND IMPACT ON COMPETING-RISK MORTALITY(2020)
Authors: Giorgio Gandaglia, Robert Jeffrey Karnes, Gaëtan Devos, Charlien Berghen, Wouter Everaerts, Giovanni Motterle, Steven Joniau, Andries Clinckaert, Daniele Robesti, Filippo Scalvi, et al.
Pages: E1131 - E1132 - CHANGING PATTERNS AND PREDICTORS OF SALVAGE RADIATION THERAPY USE OVER TIME IN PATIENTS TREATED FOR POST-PROSTATECTOMY BIOCHEMICAL RECURRENCE: A TREND ANALYSIS OVER A 20-YEAR PERIOD FROM A MULTI-INSTITUTIONAL SERIES(2020)
Authors: Elio Mazzone, Nicola Fossati, Jeffrey Karnes, Stephen A Boorjian, Giovanni Motterle, Alberto Bossi, Tamizhanban Kumar, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, et al.
Pages: E567 - E567 - PERFORMANCE CHARACTERISTICS OF PET/CT SCAN IN MEN TREATED WITH SALVAGE LYMPH NODE DISSECTION FOR RECURRENT PROSTATE CANCER: A PER PATIENT ANALYSIS WITH PATHOLOGICAL CONFIRMATION ACCORDING TO EACH AREA OF DISSECTION(2020)
Authors: Carlo Bravi, Nicola Fossati, Giovanni Motterle, Jeffrey Karnes, Maximilian Schmautz, Axel Heidenreich, Alexander Kretschmer, Alexander Buchner, Christian Stief, Gaëtan Devos, et al.
Pages: E1215 - E1216 - ASSESSING THE IMPACT OF SALVAGE RADIATION THERAPY FIELD AFTER RADICAL PROSTATECTOMY: A LONG-TERM ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES(2020)
Authors: Nicola Fossati, Jeffrey Karnes, Stephen A Boorjian, Giovanni Motterle, Alberto Bossi, Tamizhanban Kumar, Nadia Di Muzio, Cesare Cozzarini, Barbara Noris Chiorda, Elio Mazzone, et al.
Pages: E566 - E567 - THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN THE CONTEMPORARY MANAGEMENT OF METASTATIC KIDNEY CANCER: PREDICTIVE FACTORS FOR SURGICAL COMPLICATIONS AND ONCOLOGICAL SURVIVAL(2020)
Authors: Eduard Roussel, Annelies Verbiest, Uros Milenkovic, Wouter Everaerts, Ben Van Cleynenbreugel, Gaëtan Devos, Hendrik Van Poppel, Steven Joniau, Benoit Beuselinck, Maarten Albersen
Pages: E200 - E200 - RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY IN M1A AND LOW VOLUME M1B PROSTATE CANCER PATIENTS: AN INDIRECT COMPARISON WITH THE STAMPEDE TRIAL ARM H(2020)
Authors: Giorgio Gandaglia, Axel Heidenreich, David Pfister, Shahrokh Shariat, Bernhard Grubmuller, Giovanni Motterle, Gaëtan Devos, Daniele Robesti, Filippo Scalvi, Giuseppe Fallara, et al.
Pages: E364 - E364